Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

78956

registered interest
date	18/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Accident and Emergency Departments
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether they intend to take action to improve accident and emergency unit waiting times, in the light of reported missed targets over the last year.
tabling member printed	Lord Taylor of Warwick
uin	HL1273
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>National Health Service accident and emergency (A&amp;E) departments are measured against a standard that at least 95% of patients should be admitted, transferred or discharged within four hours of arrival. The standard applies to all types of (A&amp;E) departments, including major (A&amp;E) departments, minor injury units, and walk-in centres.</p><p> </p><p>This standard was met in all four quarters and for the whole of 2013-14, with performance at 95.7% for the year. It has been met for the first quarter (April to June) of 2014-15, with performance at 95.1%.</p><p> </p><p>There were 21.8 million attendances at (A&amp;E) departments in 2013-14 compared to 20.5 million in 2009-10, and in the face of rising demand not all patients are receiving care within the standard. NHS England, the NHS Trust Development Authority and Monitor are working with the most challenged providers and commissioners. £400 million has been made available this year to ensure local urgent and emergency care services are sustainable and prepared for winter.</p><p> </p> answering member printed Earl Howe question first answered 22/07/2014 16:29:07 answering member 2000 label Biography information for Earl Howe
tabling member	1796 label Biography information for Lord Taylor of Warwick

78867

registered interest
date	17/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	King's College London
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the impact of proposals by King's College London to reduce scientific staff posts in the South London<i></i>and Maudsley<i></i>catchment area by 10 to 15 per cent in (1) clinical services, (2) autism research, and (3) mental health research.<i></i>
tabling member printed	Baroness Browning
uin	HL1257
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>It is not for the Government but for local hospitals to decide how many staff they employ. Local National Health Service organisations are best placed to determine the skill mix of their workforce and must have freedom to deploy staff in ways appropriate for their locality.</p><p> </p><p>Safe staffing is not solely about numbers, but also importantly about the quality of care patients receive and how staff spend their time.</p><p> </p> answering member printed Earl Howe question first answered 22/07/2014 16:28:07 answering member 2000 label Biography information for Earl Howe
tabling member	236 label Biography information for Baroness Browning

78314

registered interest
date	16/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hearing Aids
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the case for providing hearing aids free at the point of delivery to people with mild to moderate hearing loss.
tabling member printed	Baroness Howe of Idlicote
uin	HL1204
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>The Government has not undertaken any assessments of this kind. Local commissioners are responsible for commissioning the provision of hearing aids for mild to moderate hearing loss, based on the needs of their local population. In doing so, they will take into consideration assessments of local need and any relevant clinical guidance, which may include guidance from appropriate national bodies such as the National Institute for Health and Care Excellence.</p> answering member printed Earl Howe question first answered 22/07/2014 16:26:57 answering member 2000 label Biography information for Earl Howe
tabling member	3610 label Biography information for Baroness Howe of Idlicote

78224

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what plans, if any, they have to introduce the human papilloma virus vaccine for boys.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1119
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p>The Joint Committee on Vaccination and Immunisation (JCVI), the Government’s expert advisers on immunisation matters, has set up a human papillomavirus (HPV) sub-committee to consider a number of key issues around HPV vaccination, including vaccinating men who have sex with men (MSM) and potential extension of the current programme to include adolescent boys.</p><p> </p><p>The HPV sub-committee will report its findings to the JCVI following consideration of studies by Public Health England on the impact and cost-effectiveness of extending HPV vaccination to MSM or adolescent boys. It is expected that the MSM modelling study will be completed at the end of 2014 at the earliest, and the adolescent boys modelling study will be completed at the end of 2015 at the earliest</p><p><strong> </strong></p><p>The Department will consider carefully the advice from the JCVI once it has completed its assessment.</p> answering member printed Earl Howe question first answered 23/07/2014 12:33:02 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

78225

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Human Papillomavirus
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what assessment they have made of the care received by girls suffering from vaccine injury related to the human papilloma virus vaccine.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1120
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p>The Department has not made such an assessment. The Medicines and Healthcare products Regulatory Agency (MHRA), has closely evaluated the safety of Human papillomavirus (HPV) vaccine since introduction in the national immunisation programme in 2008. In September 2012 the MHRA sought advice from the Commission on Human Medicines (CHM) on the safety of HPV vaccine, which advised that no new safety concerns have been identified and the balance of risks and benefits of the vaccine remains positive.</p><p><strong> </strong></p><p>The MHRA reviews are available on the MHRA website:</p><p> </p><p><a href="http://www.mhra.gov.uk/HPVvaccine" target="_blank">www.mhra.gov.uk/HPVvaccine</a>.</p><p> </p><p>The MHRA continues to closely evaluate the safety of Gardasil HPV vaccine since it replaced Cervarix in 2012.</p> answering member printed Earl Howe question first answered 23/07/2014 12:32:18 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

78226

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sickle Cell Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how many patients in each parliamentary constituency have sickle cell disease.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1121
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p>The vast majority of sickle cell disease (SCD) affected children born in England are identified by the NHS Sickle Cell and Thalassaemia Screening programme, and other patients may present through migration or late diagnosis</p><p> </p><p>SCD is a lifelong condition, and NHS England provides high quality care for patients with SCD as part of its specialised commissioning responsibilities. NHS England’s Haemaglobinopathies service specification clearly sets out what providers must have in place for providers to offer evidence-based, safe and effective services.</p><p> </p><p>Although SCD patient care will be coordinated by a Specialist Haemoglobinopathy Centre (SHC), the majority of care may be delivered outside of the SHC by a range of providers. The configuration of care provision will be based on local prevalence, expertise and availability of service providers, and this may include acute hospitals, community care, primary care and the voluntary sector.</p><p> </p><p>Information concerning the number of SCD patients in each parliamentary constituency is not collected. However, NHS England’s service specification sets out that there are around 15,000 patients with SCD living in England at present. In England SCD occurs predominantly, but not exclusively, in ethnic minority communities. It is the most common inherited condition in England and around 350 babies with SCD are born each year.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1122 HL1123 question first answered 23/07/2014 12:31:24 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

78227

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sickle Cell Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what trends they have identified in the prevalence of sickle cell disease in the United Kingdom over the last 10 years.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1122
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p>The vast majority of sickle cell disease (SCD) affected children born in England are identified by the NHS Sickle Cell and Thalassaemia Screening programme, and other patients may present through migration or late diagnosis</p><p> </p><p>SCD is a lifelong condition, and NHS England provides high quality care for patients with SCD as part of its specialised commissioning responsibilities. NHS England’s Haemaglobinopathies service specification clearly sets out what providers must have in place for providers to offer evidence-based, safe and effective services.</p><p> </p><p>Although SCD patient care will be coordinated by a Specialist Haemoglobinopathy Centre (SHC), the majority of care may be delivered outside of the SHC by a range of providers. The configuration of care provision will be based on local prevalence, expertise and availability of service providers, and this may include acute hospitals, community care, primary care and the voluntary sector.</p><p> </p><p>Information concerning the number of SCD patients in each parliamentary constituency is not collected. However, NHS England’s service specification sets out that there are around 15,000 patients with SCD living in England at present. In England SCD occurs predominantly, but not exclusively, in ethnic minority communities. It is the most common inherited condition in England and around 350 babies with SCD are born each year.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1121 HL1123 question first answered 23/07/2014 12:31:24 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

78228

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sickle Cell Diseases
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government what is their strategy towards the treatment of sickle cell disease.
tabling member printed	Lord Hunt of Kings Heath
uin	HL1123
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p>The vast majority of sickle cell disease (SCD) affected children born in England are identified by the NHS Sickle Cell and Thalassaemia Screening programme, and other patients may present through migration or late diagnosis</p><p> </p><p>SCD is a lifelong condition, and NHS England provides high quality care for patients with SCD as part of its specialised commissioning responsibilities. NHS England’s Haemaglobinopathies service specification clearly sets out what providers must have in place for providers to offer evidence-based, safe and effective services.</p><p> </p><p>Although SCD patient care will be coordinated by a Specialist Haemoglobinopathy Centre (SHC), the majority of care may be delivered outside of the SHC by a range of providers. The configuration of care provision will be based on local prevalence, expertise and availability of service providers, and this may include acute hospitals, community care, primary care and the voluntary sector.</p><p> </p><p>Information concerning the number of SCD patients in each parliamentary constituency is not collected. However, NHS England’s service specification sets out that there are around 15,000 patients with SCD living in England at present. In England SCD occurs predominantly, but not exclusively, in ethnic minority communities. It is the most common inherited condition in England and around 350 babies with SCD are born each year.</p><p> </p> answering member printed Earl Howe grouped question UIN HL1121 HL1122 question first answered 23/07/2014 12:31:23 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

78233

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how much has been spent on research into the causes of, and treatment and cure for, motor neurone disease by all publicly funded departments and bodies in each year since 2010.
tabling member printed	Lord Foulkes of Cumnock
uin	HL1128
answer	answer is ministerial correction date of answer 23/07/2014 answer text <p> </p><p>The following table shows expenditure on research on motor neurone disease (MND) and amyotrophic lateral sclerosis (ALS - a sub type of MND) by the Medical Research Council and by the National Institute for Health Research (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p>£ million</p><p><em> </em></p><table><tbody><tr><td><p> </p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>n/a</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.6</p></td><td><p>4.6</p></td><td><p>4.8</p></td><td><p>n/a</p></td></tr></tbody></table><p> </p><p>Total spend by the NIHR on MND/ALS is higher than this because expenditure by the NIHR Clinical Research Network (CRN) on this topic cannot be disaggregated from total CRN expenditure.</p> answering member printed Earl Howe question first answered 23/07/2014 12:25:56 answering member 2000 label Biography information for Earl Howe
tabling member	579 label Biography information for Lord Foulkes of Cumnock

78256

registered interest
date	15/07/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prescriptions
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government, in the light of physiotherapists and podiatrists being trained as independent prescribers, what progress is being made to extend prescribing to include other groups of allied health professionals.
tabling member printed	Baroness Golding
uin	HL1151
answer	answer is ministerial correction date of answer 22/07/2014 answer text <p>NHS England is working closely with the relevant professional bodies and the Department to keep the case for any further expansion of prescribing responsibilities for the allied health professions under review.</p> answering member printed Earl Howe question first answered 22/07/2014 16:25:46 answering member 2000 label Biography information for Earl Howe
tabling member	281 label Biography information for Baroness Golding